8legs: Breckenridge pharmaceuticals

Your Followed Topics

#1 out of 10.00%

Breckenridge launched a generic tofacitinib tablet, challenging Pfizer’s Xeljanz in the RA market.
The generic’s market entry may increase supply and put pricing pressure on Pfizer’s RA drug sales.
Pfizer licensed Chai Discovery’s AI platform to speed drug discovery.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.